CD8A and tuberculosis: Comparison of MPECs and SLECs in different vaccination groups once again demonstrated an increased expansion of CD8 T MPECs by Inarigivir BCG combination that was superior to MDP-BCG combination (Figure 6D). Since levels of CD4 and CD8 SLECs was not significantly different among the different vaccination groups, we suggest that SLECs may be less important for Inarigivir mediated protective immune response against tuberculosis (Figure 6D).